03:15 AM EDT, 09/23/2026 (MT Newswires) -- BSF Enterprise (BSFA.L) received a notice of allowance from the US Patent and Trademark Office for a new patent covering the use of a bioactive peptide to boost collagen production in cells. The British tissue-engineering biotechnology company said Wednesday the patent, which will be held by the company's 3D Bio-Tissues unit, is set to boost its patent portfolio and US footprint. BSF Enterprise added that the patent will be issued after payment of the standard administrative issue fee.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.